TAG:
managed care companies
Curse Of Consolidation Plagues Health Providers
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
WITHOUT QUESTION, today’s healthcare world is dominated by a single obvious trend: consolidation. The consequences of consolidation affect every segment of healthcare in the United States. The commercial laboratory industry had the dubious distinction of being the first major segment of healthcare…
“September 28, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
Just days ago, Bayer AG announced one of the largest drug-discovery alliances ever created. Bayer will pay Millennium Pharmaceuticals, Inc. $465 million. In return, over a six-year period, Millennium will use genomics techniques to identify cures for various diseases…
September 8, 1998 Intelligence: Late Breaking Lab News
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
If any one individual was to be credited with creating the modern commercial laboratory organization, it would be Paul Brown, M.D., founder and former Chairman of MetPath, Inc. (now Quest Diagnostics Incorporated). Where is he now? For ten years, he served as a Direc…
United Health’s Big Losses Derail Merger With Humana
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: Considered the darling of the managed care industry by investors, United Healthcare’s huge write-down makes it the latest healthcare behemoth to post an immense loss. Laboratory executives should see this as a sign that even big healthcare companies are struggling to develop fiscal sta…
“Corporatized” Healthcare Encountering Big Losses
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: When the clinical laboratory industry found itself losing hundreds of millions of dollars in recent years, few people imagined that billion-dollar HMO and PPM companies would soon experience similar losses. Current trends in the managed care marketplace indicate that problems…
Humana, Inc. Acquired By United Healthcare
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Clinical laboratories will see increased concentration of laboratory purchasing as a result of this merger. The combined company will insure 19.2 million people in 48 states. This transaction confirms that consolidation proceeds in all areas of the healthcare industry, despit…
HMOs Planning Double Digit Premium Increases For 1999
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
EXPECT THE HMO INDUSTRY TO PUSH double digit premium increases on employers for 1999. This will cause political and financial repercussions which impact clinical laboratories. “I think the honeymoon is over,” stated Henry Moyer, healthcare consultant with New York-based Hirschfield, Ster…
“Disease Management” Firms, Niche Labs Release Financials
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
Two DISEASE MANAGEMENT FIRMS enjoyed strong revenue growth during the first quarter of 1998. UroCor, Inc. and Impath Inc. posted revenue increases of 31% and 49%, respectively, over first quarter 1997. UroCor is the disease management company which serves urologists…
AutoPap System Cleared For Primary Screening
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
CEO SUMMARY: It is time for pathologists and cytologists to buckle their safety belts. The marketplace for automated cytology is entering a new cycle of rapid change. NeoPath’s AutoPap System is now poised to demonstrate that it is economical and clinically viable. Expect continual impr…
Bio-Reference Labs Buys New York-Based Medilabs
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: Here is an independent commercial laboratory that shows sustained growth while it maintains profitable operations. One key strategy is the selective acquisition of laboratory business in small, profitable chunks. The sales price paid for Medilabs demonstrates how much decline…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized